Diacylglycerol acyltransferase 1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats
Diacylglycerol acyltransferase 1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats
dc.audience | researchers | es_MX |
dc.contributor.author | Gustavo Pacheco-Lopez, 0000-0002-3458-197X | |
dc.contributor.other | Schober, Gundrun | |
dc.contributor.other | Arnold, Myrtha | |
dc.contributor.other | Birtles, Susan | |
dc.contributor.other | Buckett;, Linda K. | |
dc.contributor.other | Turnbull, Andrew V. | |
dc.contributor.other | Langhans, Wolfgang | |
dc.contributor.other | Mansouri, Abdelhak | |
dc.coverage | MX | es_MX |
dc.date.accessioned | 2018-05-30T18:23:20Z | |
dc.date.available | 2018-05-30T18:23:20Z | |
dc.date.issued | 2013 | |
dc.description | Acyl CoA: diacylglycerol acyltransferase-1 (DGAT-1) catalyzes the final step in triacylglycerol (TAG) synthesis and is highly expressed in the small intestine. Because DGAT-1 knockout mice are resistant to diet-induced obesity, we investigated the acute effects of intragastric (IG) infusion of a small molecule diacylglycerol acyltransferase-1 inhibitor (DGAT-1i) on eating, circulating fat metabolites, indirect calorimetry, and hepatic and intestinal expression of key fat catabolism enzymes in male rats adapted to an 8 h feeding-16 h deprivation schedule. Also, the DGAT-1i effect on fatty acid oxidation (FAO) was investigated in enterocyte cell culture models. IG DGAT-1i infusions reduced energy intake compared with vehicle in high-fat diet (HFD)-fed rats, but scarcely in chow-fed rats. IG DGAT-1i also blunted the postprandial increase in serum TAG and increased β-hydroxybutyrate levels only in HFD-fed rats, in which it lowered the respiratory quotient and increased intestinal, but not hepatic, protein levels of Complex III of the mitochondrial respiratory chain and of mitochondrial hydroxymethylglutaryl-CoA synthase. Finally, the DGAT-1i enhanced FAO in CaCo2 (EC50 = 0.3494) and HuTu80 (EC50 = 0.00762) cells. Thus, pharmacological DGAT-1 inhibition leads to an increase in intestinal FAO and ketogenesis when dietary fat is available. This may contribute to the observed eating-inhibitory effect. | es_MX |
dc.format | application/pdf | es_MX |
dc.identificador.materia | 3 | es_MX |
dc.identifier.uri | http://hdl.handle.net/20.500.12222/35 | |
dc.language | eng | es_MX |
dc.publisher | Universidad Autónoma Metropolitana. Unidad Lerma | es_MX |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.license | info:eu-repo/semantics/openAccess | es_MX |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | es_MX |
dc.subject | MEDICINA Y CIENCIAS DE LA SALUD | es_MX |
dc.subject.keywords | Triacilglicerol; | es_MX |
dc.subject.keywords | Cetogénesis; | es_MX |
dc.subject.keywords | Intestino delgado; | es_MX |
dc.subject.keywords | Enterocitos; | es_MX |
dc.subject.keywords | Dieta rica en grasas; | es_MX |
dc.subject.keywords | Alimentación; | es_MX |
dc.subject.keywords | Acil CoA: | es_MX |
dc.subject.keywords | Diacilglicerol aciltransferasa-1Triacylglycerol; | es_MX |
dc.subject.keywords | Ketogenesis; | es_MX |
dc.subject.keywords | Acyl CoA iacylglycerol acyltransferase-1 | es_MX |
dc.subject.keywords | Small intestine; | es_MX |
dc.subject.keywords | Enterocytes; | es_MX |
dc.subject.keywords | Hi | es_MX |
dc.title | Diacylglycerol acyltransferase 1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats | es_MX |
dc.type | preprint | es_MX |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_MX |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: